Nali, Luiz Henrique da Silva <br/><br/>
Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients.  [electronic resource] 

 -  Arquivos de neuro-psiquiatria  Dec 2014 
 - 960-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1678-4227 
<br/><br/><label>Standard No.: </label>10.1590/0004-282X20140142  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>DNA, Viral<br/>Female<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>JC Virus--genetics<br/>Leukoencephalopathy, Progressive Multifocal--immunology<br/>Multiple Sclerosis--drug therapy<br/>Natalizumab<br/>Risk Assessment<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load